Abstract
Abstract
Background
A condition-specific instrument is necessary to measure the health-related quality of life among those with polycystic ovary syndrome (PCOS), the most common chronic endocrinopathy among women. The first instrument was developed in 1988, followed by several revisions. However, further recommendations from all versions include additional application and measurement among different cultural populations of women with PCOS and psychometric testing based on use among larger samples of women with PCOS. Thus, the purpose of this study was to explore the factor structure of the Polycystic Ovary Syndrome Questionnaire (PCOSQ-50) using an international cross-sectional survey data from women with PCOS aged 18–42 years.
Methods
Using data from the largest known international cross-sectional study of women with PCOS aged 18–42 years (n = 935) to date, exploratory factor and confirmatory analyses were conducted for the PCOSQ-50, followed by factor labeling using a thematic analysis approach.
Results
Respondents were 31.0 ± 5.8 years of age, mostly White (72%), well-educated (56% had a college degree), married (69%), and employed full-time (65%). Three-quarters (74%) of the sample had one or more chronic conditions in addition to PCOS. Approximately 20% of the respondents originated from countries such as the United Kingdom, Australia, South Africa, etc. The PCOSQ-50 demonstrated good reliability but may be best described using a 7-factor model. The 7-factor model revealed goodness-of-fit. Thematic analysis suggested the following labels of those seven factors: hirsutism, fertility, isolation/trepidation, sexual function, self-esteem, emotional, and obesity.
Conclusion
More research is needed to adapt the current PCOSQ-50, as well as to create an age-appropriate PCOS-specific HRQoL instrument for peri-postmenopausal women with PCOS.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,General Medicine
Reference31 articles.
1. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334(13):835–40. https://doi.org/10.1056/NEJM199603283341306.
2. Centers for Disease Control and Prevention. (2021). HRQoL Concepts. CDC. Retrieved 10 December 2022, from https://www.cdc.gov/hrqol/concept.htm.
3. RAND. 36-Item Short Form Survey from the RAND Medical Outcomes Study. RAND Corporation; 2016. Retrieved 16 October 2022, from http://www.rand.org/health/surveys_tools/mos/mos_core_36item.html.
4. Azziz, R. Epidemiology and pathogenesis of the polycystic ovary syndrome in adults. (2020). UptoDate. http://www.uptodate.com/contents/epidemiology-and-pathogenesis-of-the-polycysticovary-syndrome/.
5. Moghadam ZB, Fereidooni B, Saffari M, Montazeri A. Measures of health-related quality of life in PCOS women: a systematic review. Int J Women's Health. 2018;10:397–408. https://doi.org/10.2147/ijwh.s165794.